Assessment of the MRI and Behavioral Test Results in a Focal Cerebral Ischemia-Reperfusion Model in the Rat after Separate and Combined Use of Mouse-Derived Neural Progenitor Cells, Human-Derived Neural Progenitor Cells and Atorvastatin.

CONCLUSION: Both hNPC and mNPC treatments significantly improved functional outcome, and reduced infarct area ratio after stroke. Atorvastatin enhanced the therapeutic potency of NPCs, including neurological improvement. PMID: 30192361 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30192361?dopt=Abstract

Source: Turkish Neurosurgery - September 9, 2018 Category: Neurosurgery Authors: Tahta A, Izgi N, Bagci-Onder T, Erdag E, Aras Y, Genc C Tags: Turk Neurosurg Source Type: research